{"schema_version":"secwatch.filing_event.v1","accession":"0000785161-23-000037","form_type":"8-K","ticker":"EHC","cik":"0000785161","company_name":"Encompass Health Corp","filed_at":"2023-05-19T23:59:59+00:00","discovered_at":"2026-05-14T18:03:42.222950+00:00","generated_at":"2026-06-14T20:22:04.365646+00:00","sec_items":["7.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"confidence":"high","headline":"Encompass Health reiterates FY2023 guidance at investor meeting on May 22","bullets":["Reaffirms FY2023 net operating revenue of $4,700M-$4,770M.","Reaffirms FY2023 Adjusted EBITDA of $870M-$910M.","Reaffirms FY2023 Adjusted EPS of $2.94-$3.23.","CEO Mark Tarr and CFO Doug Coltharp to participate in investor meeting in Birmingham, AL on May 22, 2023.","Guidance unchanged from April 27, 2023 earnings release and April 28, 2023 conference call."],"urls":{"canonical":"https://secwatch.observer/filing/0000785161-23-000037","json":"https://secwatch.observer/filing/0000785161-23-000037.json","markdown":"https://secwatch.observer/filing/0000785161-23-000037.md","text":"https://secwatch.observer/filing/0000785161-23-000037.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/785161/000078516123000037/0000785161-23-000037-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/785161/000078516123000037/ehc-20230519.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-14T20:22:04.365646+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}